This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Peptide Based Cancer Therapeutics Market

Peptide Based Cancer Therapeutics Market

Peptide Based Cancer Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Peptide Based Cancer Therapeutics Market
  • Mar-2022
  • List of Tables : 150
  • List of Figures : 48
  • 170 Pages
  • Healthcare


Peptide based cancer therapeutics are yet to become widespread, but the initial low numbers certainly do not suggest any pessimism in the global market. With new developments in delivery, stability, modifications, and preclinical success, future growth potentials of such cancer therapeutics continue to intensify.

A slew of new peptides with positive preclinical results are entering into clinical trials that are focused on cancer treatment.

Moreover, the application base of peptides is steadily expanding to other therapeutic areas as well. In the near future, the global peptide based cancer therapeutics market is likely to be influenced by the rising prevalence of cancer across the globe.

WHO reveals that cancer is one of the leading causes of death worldwide, which accounted for more than 8 million deaths in 2015. Factor as such are expected to play an important role in boosting the popularity of peptide based cancer therapeutics further.

In addition, various complications involved in conventional cancer therapeutics as well as the risk of sever side-effects are prompting medical professionals to utilise peptides in tumor and cancer treatment.

Fact.MR’s latest report projects that the global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end, expanding at an impressive CAGR of 9.2% during the forecast period (2017-2022).

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.

At present, there are a number of peptide based cancer therapeutics available in the market. Incessant medical research on peptides has led to development of several peptide based cancer therapeutics that are showing greater results as compared to conventional cancer therapeutics.

Avail customized purchase options for your needs

North America To Lead The Global Peptide Based Cancer Therapeutics Market

In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region’s potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market.

Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

An Adaptive Approach to Modern-day Research Needs

Competition Tracking

Fact.MR’s report has also profiled key companies that are operating in the global peptide based cancer Therapeutic market, which include

  • AstraZeneca PLC
  • Allergan plc
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • Abbott
  • AbbVie Inc.
  • and Valeant Pharmaceuticals International Inc.

Interested to Procure The Data

Market Taxonomy

  • Goserelin
  • Bortezomib
  • leuprorelin
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

- FAQs -

The global Peptide Based Cancer Therapeutics market is likely to reach a valuation of US$ 11,160 Mn by the end of 2022.
Some of the key players in global Peptide Based Cancer Therapeutics market are AstraZeneca PLC, Allergan plc, Pfizer Inc., Abbott and many more.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Aptamers Market

The global aptamer market to progress at an impressive pace, at a CAGR of 21% during the forecast pe...

Peptide Based Cardiovascular Therapeutics Market

The global peptide-based cardiovascular therapeutics market will surpass the value of US$ 1,960 Mn b...

Genetic Disorder Therapeutics Market

Genetic Disorder Therapeutics Market research report covers detailed information on Global Genetic D...

Bipolar Disorder Therapeutics Market

Bipolar Disorder Therapeutics Market will account for US$ 5.9 Bn in 2022 and reach a value of US$ 6....

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.